Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck

Go back to Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.75 +2.86 (2.73%)
Previous Close $104.89    52 Week High $18.39 
Open $106.39    52 Week Low $6.96 
Day High $107.96    P/E N/A 
Day Low $105.50    EPS $-0.58 
Volume 1,671,581       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1286.37 +60.64 (4.95%)
Previous Close $1225.73    52 Week High $88.16 
Open $1245.81    52 Week Low $67.88 
Day High $1292.65    P/E 297.77 
Day Low $1240.54    EPS $4.32 
Volume 3,320,675       

Medtronic Inc. (NYSE: MDT) Delayed: 93.91 +1.82 (1.98%)
Previous Close $92.09    52 Week High $89.27 
Open $92.38    52 Week Low $71.03 
Day High $94.72    P/E 26.68 
Day Low $91.95    EPS $3.52 
Volume 3,641,616       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 46.72 +1.01 (2.21%)
Previous Close $45.71    52 Week High $59.00 
Open $46.01    52 Week Low $32.80 
Day High $47.20    P/E N/A 
Day Low $45.84    EPS $0.00 
Volume 12,593,495       

SANOFI (NASDAQ: SNY) Delayed: 45.88 +0.91 (2.02%)
Previous Close $44.97    52 Week High $44.76 
Open $45.42    52 Week Low $36.81 
Day High $46.02    P/E N/A 
Day Low $45.42    EPS $0.00 
Volume 2,048,548